Direct-to-patient Teledermatology and Computer-assisted Diagnosis

NCT05128006 | Recruiting

• 2 other identifiers: IIR 21-103HX003473
• Study Type: observational
• Target: 63,200
• Locations: 1 country
• Sites: 3

Brief Summary

This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.

Conditions

New Patient Use of Teledermatology Mobile App

Keywords

teledermatology; ehealth; mobile health; telemedicine; artificial intelligence; telehealth; access

Outcome Measures

Primary Outcomes (10)

• New patient in-person dermatology visits

  Proportion of in-person dermatology visits that are for new dermatology patients at facility level

  4 years

• Consult completion time

  Total time in days from consult request date to consult completion date, excluding discontinued consults.

  4 years

• Appointment completion time

  Total time in days from appointment create date to appointment completed date following (in-person groups).

  4 years

• Travel distance for VA care

  Average driving distance from the centroid of the patient's residential zip code to physical location of VA dermatology care. Distances for MVAI cases are defined as zero.

  4 years

• Third next available dermatology clinic appt completion time

  Total time in days from appointment create date to third next available clinic appointment date. A forward-looking measure of access. While not as reliable as consult completion time, it is frequently used in VA as a practical forward-looking measure of access.

  4 years

• New Patient Teledermatology encounters

  New TD visits as fraction of total encounters at each facility reflecting degree of TD integration.

  4 years

• Organizational Readiness to implement mobile teledermatology for direct new patient care

  Using the Organizational Readiness for Implementing Change survey the investigators will attain an overall average score by facility and a score for the 3 facilities in the study combined to indicate organizational readiness to implement a new patient mobile teledermatology. The score is derived from a Likert response scale from 1 to 5. Higher score denotes higher organizational readiness.

  4 years

• Readiness of Veterans to use mobile teledermatology for direct new patient care

  The investigators will assess readiness of Veterans to use mobile teledermatology for a new patient visit with a new survey. The investigators will use a 5 point scale, the higher score the greater readiness.

  4 years

• Patient Satisfaction of different types of dermatologic care

  Assessment of satisfaction of dermatologic care. A new survey was created with questions regarding ease of care and barriers, for example. The investigators will use a 5-point scale, the higher the score the greater the satisfaction.

  4 years

• Readiness of Veterans to use Artificial Intelligence for dermatologic care

  The investigators will assess readiness of Veterans to use Artificial Intelligence for dermatologic care with a new survey. The investigators will use a 5 point scale, the higher score the greater readiness.

  4 years

Secondary Outcomes (2)

• Scheduled compared to clinically indicated appointment date

  4 years

• Whether patient had a no-show event for an intended encounter

  4 years

Study Arms (4)

In-person new VA dermatology patients

In-person dermatology patients that are new patients at three facilities

New patient consultative Teledermatology users

New patient consultative Teledermatology users at three facilities

New patient Mobile teledermatology users

New patient Mobile teledermatology users at three facilities

Other: New patient teledermatology visit

In-person new patient in Community Care

In-person new patient in Community Care

Interventions

New patient teledermatology visit OTHER

new patient teledermatology visits

New patient Mobile teledermatology users

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients referred as new patients to dermatology at sites in study.

You may qualify if:

• New patient referrals to dermatology at San Francisco, Decatur, and Aurora from 2021-2025

You may not qualify if:

• Patients who are not dermatology patients
• Dermatology patients who are not seen at San Francisco, Decatur, and Aurora
• Dermatology patients at San Francisco, Decatur, and Aurora who have visits only before 2021 or after 2025

Sponsors & Collaborators

• Providence VA Medical Center: collaborator
• VA Office of Research and Development: lead
• VA Boston Healthcare System: collaborator
• Durham VA Health Care System: collaborator

Study Sites (3)

San Francisco VA Medical Center, San Francisco, CA

San Francisco, California, 94121-1563, United States

RECRUITING

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, 80045-7211, United States

RECRUITING

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, 30033-4004, United States

RECRUITING

Study Officials

• Dennis H. Oh, MD PhD

  San Francisco VA Medical Center, San Francisco, CA

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Dennis H Oh, MD PhD

CONTACT

(415) 750-2091; Dennis.Oh@va.gov

Sara B Peracca, PhD MPH MS

CONTACT

(415) 221-4810; sara.peracca@va.gov

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: FED
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 22, 2021
• First Posted: November 19, 2021
• Study Start: November 7, 2022
• Primary Completion (Estimated): June 30, 2026
• Study Completion (Estimated): September 30, 2026
• Last Updated: January 23, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (3)